Trends of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae in Europe
Open Access
- 1 December 2004
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 54 (6) , 1045-1050
- https://doi.org/10.1093/jac/dkh458
Abstract
Objectives: To forecast trends in resistance to penicillin and erythromycin among Streptococcus pneumoniae in Europe. Methods: Since 1999, the European Antimicrobial Resistance Surveillance System (EARSS) has collected routine antimicrobial susceptibility test results of S. pneumoniae. To observe and predict changes of reduced susceptibility over time, we used a multinomial logistic regression model. Results: Large variations in penicillin and erythromycin non-susceptibility were observed between countries, and reduced susceptibility to erythromycin (17%) has become more frequent than reduced susceptibility to penicillin (10%) in Europe overall. An overall decrease in single penicillin non-susceptibility, but an increase in dual non-susceptibility was observed, indicating a shift of single penicillin to combined non-susceptibility with erythromycin. By 2006, the proportion of single erythromycin and dual non-susceptibility could increase to as much as 20.4% and 8.9%, respectively. Conclusions: Our results indicate that appropriately dosed β-lactams for empirical therapy are still the treatment of choice, and that macrolides should be used with prudence.Keywords
This publication has 22 references indexed in Scilit:
- The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agentsJournal of Antimicrobial Chemotherapy, 2003
- Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United StatesNature Medicine, 2003
- Comparability of antimicrobial susceptibility test results from 22 European countries and Israel: an external quality assurance exercise of the European Antimicrobial Resistance Surveillance System (EARSS) in collaboration with the United Kingdom National External Quality Assurance Scheme (UK NEQAS).Journal of Antimicrobial Chemotherapy, 2002
- Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and compatative in vitro activity of the ketolide, telithromycinJournal of Antimicrobial Chemotherapy, 2002
- Rapid increase in macrolide resistance among penicillin non-susceptible pneumococci in Finland, 1996-2000Journal of Antimicrobial Chemotherapy, 2002
- The Continuing Challenge of Lower Respiratory Tract InfectionsClinical Infectious Diseases, 2002
- The rise and fall of antimicrobial resistanceTrends in Microbiology, 2001
- Increasing Prevalence of Multidrug-ResistantStreptococcus pneumoniaein the United StatesNew England Journal of Medicine, 2000
- Standardization and quality assurance for antimicrobial resistance surveillance of Streptococcus pneumoniae and Staphylococcus aureus within the European Antimicrobial Resistance Surveillance System (EARSS)†Clinical Microbiology & Infection, 2000
- European Antimicrobial Resistance Surveillance System (EARSS): objectives and organisationEurosurveillance, 1999